GENETIC STRAINS AND STOCKS 101 



Table 27 — Continued 



Name or 

 Symbol 



Synonym(s) 



Remarks 



101 



129 



lOlBAg 



\29-Fu 



129/Sv-CP 



129/Sv-aCP 



Sensitive to RIII milk agent (55% tumor incidence after injection of 

 newborns). Spontaneous leukemia less than 2%. Pulmonary 

 tumors 15% in $$ 12—24 mo. Sensitive to pulmonary tumor produc- 

 tion by urethan, methylcholanthrene, or X rays. Relative sensitive 

 to Gross tumor agent. Good breeders and good mothers, main- 

 tained by: Baz, Rd. 



inbr (H) : 49 + 17. genet: A u 'A w . origin: Dunn, charac: low 

 mammary tumor, slow to breed, fertility moderate. High suscepti- 

 bility to skin and pulmonary tumor induction by chemical carcinogens, 

 low leukemia, low mammary tumor, high incidence of papillonephritis. 

 maintained by: H, Lhm, Rl. 



inbr (Rr): 33. genet: A w A w c ch pjcp. H-2 b . origin: Dunn. 

 charac: useful for ovary transplant and ova transfer studies; 1% 

 incidence of testicular teratomas. Low mammary tumor incidence, 

 not susceptible to MTI. High incidence of venous congestion in 

 adrenals and uterus. Highly sensitive to estrogen at all ages. Ulti- 

 mate source of muscular dystrophy animals, maintained by: Ha, 

 Jax, Jb, Lab, Pi, Rl, Rr, Sv. 



inbr (Rr) : N13. genet: A w A w c ch p\cpFu +. origin: Fu introduced 

 in 129/Rr. charac: 48-50% penetrance of Fu. maintained by: Rr. 

 inbr (Sv): Nil + F6. genet: A w A w . origin: outcross of 129/RrSv 

 to DBA with backcross to 129 to Nl 1, b x s since then, charac: 

 useful for ovarian transplants, maintained by: Sv. 

 inbr (Sv) : Nil + F7. genet: aa. origin: spontaneous mutation 

 from A w to a detected in F 2 of 129/Sv-G>. charac: useful for ovarian 

 transplants, maintained by: Sv. 



List of symbols for designating substrains of mice 



A Antoni van Leeuwenhoekhuis, Amster- Be 



dam C, Sarphatistraat 108, Netherlands 



(Dr. O. Muhlbock). 

 Am Dr. J. L. Ambrus, Roswell Park Bi 



Memorial Institute, Buffalo 3, N.Y. 

 Ao Dr. D. B. Amos, Roswell Park Memorial 



Institute, Buffalo 3, N.Y. Bl 



An Dr. H. B. Andervont, National Cancer 



Institute, Bethesda 14, Md. 

 Anl Argonne National Laboratory, Division 



of Biological and Medical Research, 



Box 299, Lemont, 111. (Dr. Robert J. Bn 



Flynn). 

 Ba Institute de Medicina Experimental, 



Laboratorio de Genetica, Avda. San Bnd 



Martin 5481, Buenos Aires, Argentina. 

 Baz Centro per lo studio e la cura dei tumori, 



Busto Arsizio, Italy (Dr. G. Ceriotti). Bo 



Bcr University of Birmingham, Cancer 



Research Laboratories, The Medical 



School, Birmingham 15, England (Dr. Br 



June Marchant). 



Dr. R. A. Beatty, Institute of Animal 

 Genetics, West Mains Road, Edin- 

 burgh 9, Scotland. 



Dr. J. J. Bittner, University of Minne- 

 sota Medical School, Minneapolis 14, 

 Minn, (deceased). 



Drs. M. & F. Bielschowsky, Hugh 

 Adams Cancer Research Department, 

 University of Otago Medical School, 

 Great King Street, Dunedin C.I., New 

 Zealand. 



Dr. S. E. Bernstein, Roscoe B. Jackson 

 Memorial Laboratory, Bar Harbor, 

 Maine. 



Barnard College, Department of 

 Zoology, Columbia University, New 

 York 2 7, N.Y. (Dr. Reba M. Goodman). 

 Biochemical Department of Cancer 

 Institute, Zluty kopec 7. Brno, Czecho- 

 slovakia. 



Dr. G. M. Bonser, Department of 

 Experimental Pathology and Cancer 



